Oxygent
Oxygent is a human blood substitute designed for surgical applications by the Alliance Pharmaceutical Corp. As of February 2005, the substance had not been approved for use by the Food and Drug Administration (FDA) as there are questions about its safety. Phase 2 trials were announced in 2007.[1]
There are several advantages of using artificial blood substitutes instead of human blood transfusions: it will not spread blood-borne diseases; it is a universal replacement for people in any blood type; and it is acceptable to Jehovah's Witnesses who refuse human blood transfusions.[2]
Oxygent is a lecithin-stabilized emulsion of a perfluorocarbon.
See also
References
- ↑ "Alliance Pharmaceutical Corp. Completes the Manufacture of Oxygent (TM) for Clinical". noblood.org. Retrieved July 9, 2016.
- ↑ "Jehovah's Witnesses - Position Overview". Penn Medicine. November 1, 2002. Archived from the original on March 21, 2008. Retrieved July 9, 2016.
External links
- Archived page for the Oxygent website
- 2000 report on Oxygent
- Wired magazine report on Oxygent
- FDA non-binding recommendation regarding usage of perfluorocarbon (fluosol), 2004
This article is issued from Wikipedia - version of the 9/4/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.